Laurent Fischer - Feb 25, 2025 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role
CEO, PRESIDENT AND DIRECTOR, Director
Signature
/s/ Aneta Fergson, Attorney-in-Fact
Stock symbol
ADVM
Transactions as of
Feb 25, 2025
Transactions value $
$0
Form type
4
Date filed
2/27/2025, 04:05 PM
Previous filing
Aug 6, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADVM Common Stock Award $0 +25K +34.91% $0.00 96.6K Feb 25, 2025 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADVM Stock Option (Right to Buy) Award $0 +150K $0.00 150K Feb 25, 2025 Common Stock 150K $4.20 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock issuable upon settlement of a restricted stock unit ("RSU") grant that will vest as to one-third (1/3rd) of the total number of shares subject to this award on each anniversary of March 1, 2025 (the "Vesting Commencement Date"), so that all of the shares subject to the RSUs are vested on the third (3rd) annual anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each vesting date.
F2 Includes 600 shares purchased on May 20, 2023, 600 shares purchased on November 20, 2023, 600 shares purchased on May 20, 2024 and 600 shares purchased on November 20, 2024, pursuant to the Issuer's 2014 Employee Stock Plan Purchase Plan, as amended and restated.
F3 On March 21, 2024, the Common Stock of Issuer split 1-for-10, resulting in a proportionate reduction of Reporting Person's shares.
F4 Twenty-five percent (25%) of the total number shares subject to the Option shall vest and become exercisable one year after the Vesting Commencement Date, and one-forty-eighth (1/48th) of the total number of shares subject to the Option shall vest and become exercisable each month thereafter, so that all of the shares subject to the Option are vested and exercisable on the fourth (4th) anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each vesting date.